Linear IgA bullous dermatosis: a rare side effect of vancomycin

Following a motor vehicle accident, a 70-year-old white female was admitted with lower limb fractures that required operative repair. The postoperative course was complicated by sepsis. Vancomycin and piperacillin/tazobactam were initiated empirically. Five days later, she developed a pruritic maculopapular rash in the groin and axilla. The rash progressed to a non-hemorrhagic vesicles and bullae on an erythematous base and spread to involve the trunk, palms and the inner aspects of the lips. Skin biopsy and direct immunofluorescence testing were consistent with vancomycin-induced linear IgA bullous dermatosis. Vancomycin was stopped with complete resolution of the lesions in the subsequent 2 weeks. Being aware of vancomycin-induced linear IgA bullous dermatosis in patients who develop a blistering skin rash while receiving this antibiotic should lead to timely interventions. Stopping vancomycin promptly and encouraging early skin biopsy to confirm the diagnosis will prevent disease progression and avoid unnecessary costs and suffering.

[1]  T. Hashimoto,et al.  Linear immunoglobulin A bullous dermatosis possibly induced by mefenamic acid , 2010, The Journal of dermatology.

[2]  Y. Horiguchi,et al.  Linear IgA dermatosis: Report of an infantile case and analysis of 213 cases in Japan , 2008, The Journal of dermatology.

[3]  R. El-Azhary,et al.  A morbilliform variant of vancomycin-induced linear IgA bullous dermatosis. , 2008, Archives of dermatology.

[4]  N. Sepp,et al.  Vancomycin‐induced linear IgA bullous dermatosis in an immunosuppressed transplant recipient , 2007, Journal of the European Academy of Dermatology and Venereology : JEADV.

[5]  J. Callen,et al.  Vancomycin‐induced linear IgA bullous disease presenting as toxic epidermal necrolysis , 2004, Clinical and experimental dermatology.

[6]  G. Scott,et al.  A successful challenge in a patient with vancomycin-induced linear IgA dermatosis. , 2004, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[7]  Amin Fazeli,et al.  Vancomycin‐induced linear IgA disease manifesting as bullous erythema multiforme , 2004, Journal of cutaneous pathology.

[8]  Douglas H. Jones,et al.  Early Diagnosis Is Key in Vancomycin-Induced Linear IgA Bullous Dermatosis and Stevens-Johnson Syndrome , 2004, The Journal of the American Osteopathic Association.

[9]  R. Dellavalle,et al.  Vancomycin-associated linear IgA bullous dermatosis mimicking toxic epidermal necrolysis. , 2003, Journal of the American Academy of Dermatology.

[10]  R. Vodegel,et al.  IgA-mediated epidermolysis bullosa acquisita: two cases and review of the literature. , 2002, Journal of the American Academy of Dermatology.

[11]  S. Pelton,et al.  Bullous Skin Disease: An Unusual Allergic Reaction to Vancomycin , 2002, The American journal of the medical sciences.

[12]  T. Wiadrowski,et al.  Drug‐induced linear IgA bullous disease following antibiotics , 2001, The Australasian journal of dermatology.

[13]  R. Ahkami,et al.  Linear IgA bullous dermatosis associated with vancomycin and disseminated varicella-zoster infection. , 2001, Cutis.

[14]  J. Callen,et al.  Drug-induced linear IgA bullous dermatosis after vancomycin discontinuance in a patient with renal insufficiency. , 2000, Journal of the American Academy of Dermatology.

[15]  J. Caeiro,et al.  Clinical, demographic, and immunohistologic features of vancomycin-induced linear IgA bullous disease of the skin. Report of 2 cases and review of the literature. , 1999, Medicine.